☆ 4.6 Article

PHT427 as an effective New Delhi metallo-β-lactamase-1 (NDM-1) inhibitor restored the susceptibility of meropenem against Enterobacteriaceae producing NDM-1

FRONTIERS IN MICROBIOLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Microbiology

Molecular Epidemiology of New Delhi Metallo-β-Lactamase-Producing Escherichia coli in Food-Producing Animals in China

Xu Kuang et al.

Summary: This study conducted molecular surveillance on carbapenem-resistant Enterobacteriaceae (CRE) colonization in food-producing animals in China, primarily swine and poultry, over a period of three years. The results revealed that food-producing animals in China, specifically pigs and chickens, serve as an important reservoir for New Delhi metallo-beta-lactamase (NDM)-positive E. coli. Whole genome sequencing and bioinformatic analysis were used to investigate the genomic characteristics of the carbapenemase-producing isolates. The study highlights the potential threat to public health posed by NDM-positive E. coli in food-producing animals in China.

FRONTIERS IN MICROBIOLOGY (2022)

Add to Collection

Article Microbiology

Genomic Analysis of a Highly Virulent NDM-1-Producing Escherichia coli ST162 Infecting a Pygmy Sperm Whale (Kogia breviceps) in South America

Fabio P. Sellera et al.

Summary: A carbapenem-resistant NDM-1-positive Escherichia coli isolate was recovered from a stranded pygmy sperm whale in Brazil. The isolate carried multiple antimicrobial resistance genes, as well as genes associated with heavy metal and biocide resistance. It exhibited halotolerance and virulent behavior, and was closely related to poultry- and human-associated lineages circulating in Europe and Asia. The presence of carbapenemase-producing pathogens in coastal water poses an emerging threat that requires urgent assessment of the role of the aquatic environment in their global epidemiology.

FRONTIERS IN MICROBIOLOGY (2022)

Add to Collection

Article Microbiology

Emergence of a NDM-1-producing ST25 Klebsiella pneumoniae strain causing neonatal sepsis in China

Junhui Zhao et al.

Summary: This study reports the first infection caused by bla(NDM-1)-positive ST25 Klebsiella pneumoniae in a neonatal unit. The strain was highly virulent and resistant to multiple antimicrobial agents. These findings highlight the need for stricter surveillance and more effective actions to prevent the dissemination of such K. pneumoniae strains in clinical settings, especially in neonatal wards.

FRONTIERS IN MICROBIOLOGY (2022)

Add to Collection

Article Microbiology

Prevalence and risk factors of carbapenem-resistant Enterobacterales positivity by active screening in intensive care units in the Henan Province of China: A multi-center cross-sectional study

Bo Guo et al.

Summary: In ICUs in Henan Province, the positive rate of CRE was very high, mainly KPC-type CR-KPN. Prolonged ICU stay, chronic neurological disease, transfer from other hospitals, previous infection, and history of antibiotic exposure are risk factors for CRE. Age and cardiovascular diseases are susceptibility factors for mixed infections of CRE. The positive rate of CRE in tertiary hospitals was higher than that in secondary hospitals, which may be related to patient source, antibiotic exposure, disease severity, and previous infection.

FRONTIERS IN MICROBIOLOGY (2022)

Add to Collection

Article Microbiology

Beta-lactamase determinants and molecular typing of carbapenem-resistant classic and hypervirulent Klebsiella pneumoniae clinical isolates from southwest of Iran

Morteza Saki et al.

Summary: This study investigated the molecular epidemiology of carbapenem-resistant classic Klebsiella pneumoniae (CR-cKp) and carbapenem-resistant hypervirulent Klebsiella pneumoniae (CR-hvKp) isolates in southwestern Iran. The occurrence of MDR CR-hvKp isolates harboring bla(NDM) and bla(GES) was detected for the first time in this region. Long-term surveillance and more effective treatment strategies are needed to prevent the spread of CR-hvKp.

FRONTIERS IN MICROBIOLOGY (2022)

Add to Collection

Review Chemistry, Medicinal

Recent research and development of NDM-1 inhibitors

Ting Wang et al.

Summary: Bacteria carrying the New Delhi metallo-beta-lactamase-1 (NDM-1) resistance gene are a new type of superbug, with the ability to rapidly spread and exhibit broader substrate specificity, posing a serious threat to human health and public health safety due to their strong antibiotic resistance.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Add to Collection

Article Agriculture, Multidisciplinary

Identification of a New Antimicrobial Agent against Bovine Mastitis-Causing Staphylococcus aureus

Minhye Shin et al.

Summary: Staphylococcus aureus RF122 Feo system is a major pathogen causing bovine mastitis, and the new antimicrobial agent PHT-427 efficiently inhibits this system, attenuating various virulence factors related to milk quality, enhancing bacterial antibiotic susceptibility, and showing no toxicity on animal model systems.

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2021)

Add to Collection

Review Medicine, Research & Experimental

Drug repurposing for next-generation combination therapies against multidrug-resistant bacteria

Yuan Liu et al.

Summary: Antimicrobial resistance poses a global health challenge, but a combination of antibiotics and non-antibiotic compounds offers an effective strategy. A pathogen-by-pathogen approach highlights the critical value of drug repurposing.

THERANOSTICS (2021)

Add to Collection

Article Pharmacology & Pharmacy

3-Bromopyruvate as a potent covalently reversible inhibitor of New Delhi metallo-β-lactamase-1 (NDM-1)

Peng-Wei Kang et al.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2020)

Add to Collection

Article Infectious Diseases

In vivo pharmacodynamics of new-generation β-lactamase inhibitor taniborbactam (formerly VNRX-5133) in combination with cefepime against serine-β-lactamase-producing Gram-negative bacteria

Kamilia Abdelraouf et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)

Add to Collection

Review Chemistry, Medicinal

β-lactam antibiotics: An overview from a medicinal chemistry perspective

Lidia Moreira Lima et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)

Add to Collection

Review Biochemistry & Molecular Biology

New Carbapenemase Inhibitors: Clearing the Way for the β-Lactams

Juan C. Vazquez-Ucha et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Add to Collection

Review Biochemistry & Molecular Biology

β-Lactamases and β-Lactamase Inhibitors in the 21st Century

Catherine L. Tooke et al.

JOURNAL OF MOLECULAR BIOLOGY (2019)

Add to Collection

Review Chemistry, Medicinal

Ten Years with New Delhi Metallo-β-lactamase-1 (NDM-1): From Structural Insights to Inhibitor Design

Pasquale Linciano et al.

ACS INFECTIOUS DISEASES (2019)

Add to Collection

Review Biotechnology & Applied Microbiology

Antibiotics in the clinical pipeline at the end of 2015

Mark S. Butler et al.

JOURNAL OF ANTIBIOTICS (2017)

Add to Collection

Article Chemistry, Medicinal

Metallo-β-lactamase inhibitors by bioisosteric replacement: Preparation, activity and binding

Susann Skagseth et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)

Add to Collection

Article Pharmacology & Pharmacy

Identification of a Novel Liver X Receptor Agonist that Regulates the Expression of Key Cholesterol Homeostasis Genes with Distinct Pharmacological Characteristics

Ni Li et al.

MOLECULAR PHARMACOLOGY (2017)

Add to Collection

Article Medicine, General & Internal

Nationwide Surveillance of Clinical Carbapenem-resistant Enterobacteriaceae (CRE) Strains in China

Rong Zhang et al.

EBIOMEDICINE (2017)

Add to Collection

Article Chemistry, Medicinal

Antibiotic adjuvants - A strategy to unlock bacterial resistance to antibiotics

Concepcion Gonzalez-Bello

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)

Add to Collection

Review Chemistry, Medicinal

New Delhi metallo-β-lactamase-1: structure, inhibitors and detection of producers

Paul W. Groundwater et al.

FUTURE MEDICINAL CHEMISTRY (2016)

Add to Collection

Article Gastroenterology & Hepatology

Improved Treatment of Pancreatic Cancer With Drug Delivery Nanoparticles Loaded With a Novel AKT/PDK1 Inhibitor

Joseph E. Kobes et al.

PANCREAS (2016)

Add to Collection

Article Medicine, General & Internal

Will 10 Million People Die a Year due to Antimicrobial Resistance by 2050?

Marlieke E. A. de Kraker et al.

PLOS MEDICINE (2016)

Add to Collection

Review Infectious Diseases

New promising β-lactamase inhibitors for clinical use

I. Olsen

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2015)

Add to Collection

Editorial Material Pediatrics

Antimicrobial resistance - A ticking bomb!

Vijay N. Yewale

INDIAN PEDIATRICS (2014)

Add to Collection

Review Biotechnology & Applied Microbiology

Worldwide Dissemination of the NDM-Type Carbapenemases in Gram-Negative Bacteria

Laurent Dortet et al.

BIOMED RESEARCH INTERNATIONAL (2014)

Add to Collection

© Peeref 2019-2024. All rights reserved.